Over the past twenty-four months, a lot has been written about how the Covid-19 pandemic has affected consumer behavior, about patients who postponed their doctor’s visits, changed their consultation habits, etc.
This overview gives you, as a Consumer Healthcare company, insight into general observations regarding your categories within the pharmacy channel. It allows you to evaluate whether what you are experiencing today applies specifically to your company or if it is a general trend.
The purpose is to help you develop a winning & sustainable strategy within the pharmacy channel.
Download this paper now and find out how IM Associates can be valuable for you.
How to transform the Patient Journey into a forecasting model for strategic market insights? Explore how healthcare organizations can harness the power of patient journey insights to revolutionize their forecasting strategies and elevate the quality of care delivery.
This is part 1 of the paper outlining the framework on questions that should be asked to assess whether physicians are key stakeholders.
Physicians are potential stakeholders for consumer healthcare companies, shaping outcomes and patient experiences. This first part answers the question to be asked to build the business case or to evaluate today's investments into the HCP channel.
Are you stuck with daily ad hoc data crunching? Stop wasting your time.
Reliable data insights and customer centricity start
with correct data governance.
Launching a new drug or medical device? Keep in mind that a lot of subprojects and assignments need to be carried out in parallel. To realize certain important steps in your launch project, it is best to call upon an expert like IM Associates!
Many organizations compile data from various sources that are not managed centrally. This is usually not a good idea.
Reliable data insights and customer centricity start with correct data governance.
This is a guide on how to turn BI challenges into a company-wide, customer-centric, and fully data-driven strategy.
How to use 3R data to identify eligible patients in a specific indication? IM Associates translates raw data into a customized business story.
This is part two of a series of papers on how to turn BI challenges into a company-wide, customer-centric, and fully data-driven strategy.
IM Associates knows how to challenge your Go to Market strategy and how to effectively and successfully roll out the necessary post-Covid re-engineering ...
For companies specializing in Rx or generic drugs: Our view on how the pharmacy channel is a key stakeholder.
This is part one of a series of papers on how to turn BI challenges into a company-wide, customer-centric, and fully data-driven strategy.
To download the whitepaper, we ask you kindly to fill in your name and business email address in the form below